Markham, Anthony
Keam, Susan J.
Article History
First Online: 16 July 2019
Change Date: 24 August 2019
Change Type: Correction
Change Details: Page 1355, Abstract, Inline table ‘Camrelizumab (AiRuiKa™): Key Points’, and Introduction.
Compliance with Ethical Standards
:
: The preparation of this review was not supported by any external funding.
: During the peer review process the manufacturer of the agent under review was offered an opportunity to comment on the article. Changes resulting from any comments received were made by the authors on the basis of scientific completeness and accuracy. A. Markham, a contracted employee of Adis International Ltd/Springer Nature, and Susan Keam, a salaried employees of Adis International Ltd/Springer Nature are responsible for the article content and declare no relevant conflicts of interest.